Basoli, S.; Cosentino, M.; Traversari, M.; Manfrini, M.; Tsukamoto, S.; Mavrogenis, A.F.; Bordini, B.; Donati, D.M.; Errani, C.
The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities. Curr. Oncol. 2023, 30, 7043-7054.
https://doi.org/10.3390/curroncol30070511
AMA Style
Basoli S, Cosentino M, Traversari M, Manfrini M, Tsukamoto S, Mavrogenis AF, Bordini B, Donati DM, Errani C.
The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities. Current Oncology. 2023; 30(7):7043-7054.
https://doi.org/10.3390/curroncol30070511
Chicago/Turabian Style
Basoli, Stefano, Monica Cosentino, Matteo Traversari, Marco Manfrini, Shinji Tsukamoto, Andreas F. Mavrogenis, Barbara Bordini, Davide Maria Donati, and Costantino Errani.
2023. "The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities" Current Oncology 30, no. 7: 7043-7054.
https://doi.org/10.3390/curroncol30070511
APA Style
Basoli, S., Cosentino, M., Traversari, M., Manfrini, M., Tsukamoto, S., Mavrogenis, A. F., Bordini, B., Donati, D. M., & Errani, C.
(2023). The Prognostic Value of Serum Biomarkers for Survival of Children with Osteosarcoma of the Extremities. Current Oncology, 30(7), 7043-7054.
https://doi.org/10.3390/curroncol30070511
